Latest News
Dorman Products (DORM) beats Q2 2025 estimates with $541M revenue & $2.06 EPS, raises full-year guidance. Shares surge 6.69% post-earnings.
Via Chartmill · August 4, 2025
Simon Property Group (SPG) beat Q2 2025 earnings estimates, raised guidance, and increased its dividend, signaling strong financial health and investor confidence.
Via Chartmill · August 4, 2025
Hims & Hers Health reports second-quarter revenue of $544.83 million, missing analyst estimates of $549.83 million.
Via Benzinga · August 4, 2025
Castle Biosciences (CSTL) Q2 2025 earnings beat estimates with $86.19M revenue & $0.15 EPS, driving a 6% after-hours surge. Strong test volume growth fuels optimism.
Via Chartmill · August 4, 2025
V2X Inc. (NYSE:VVX) beat Q2 2025 earnings estimates, raising full-year EPS guidance. Shares surged 3.9% post-release, reflecting strong defense sector performance.
Via Chartmill · August 4, 2025
BioMarin Pharmaceutical beats Q2 2025 estimates with $825.4M revenue, EPS of $1.44, and raises full-year guidance. Stock surges 4.6% post-earnings.
Via Chartmill · August 4, 2025
Restaurant software company (NYSE:OLO) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 21.6% year on year to $85.72 million. Its non-GAAP profit of $0.07 per share was in line with analysts’ consensus estimates.
Via StockStory · August 4, 2025
James River Group's Q2 2025 earnings missed revenue estimates but showed resilience in adjusted income, with shares remaining flat post-release.
Via Chartmill · August 4, 2025
ONEOK reports Q2 2025 earnings above estimates, reaffirms full-year guidance. Strong NGL performance in Rocky Mountain region drives results. Stock rises slightly post-announcement.
Via Chartmill · August 4, 2025
Composite decking and railing products manufacturer Trex Company (NYSE:TREX) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 3% year on year to $387.8 million. On the other hand, next quarter’s revenue guidance of $300 million was less impressive, coming in 1% below analysts’ estimates. Its non-GAAP profit of $0.73 per share was 2.8% above analysts’ consensus estimates.
Via StockStory · August 4, 2025
Vertex stock crashed late Monday after the company said it wouldn't advance a next-generation pain drug into more testing.
Via Investor's Business Daily · August 4, 2025
Online fashion resale marketplace ThredUp (NASDAQ:TDUP) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 16.4% year on year to $77.66 million. On top of that, next quarter’s revenue guidance ($74 million at the midpoint) was surprisingly good and 3.7% above what analysts were expecting. Its GAAP loss of $0.04 per share was $0.01 above analysts’ consensus estimates.
Via StockStory · August 4, 2025
Medical products company UFP Technologies (NASDAQ:UFPT) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 37.2% year on year to $151.2 million. Its non-GAAP profit of $2.50 per share was 11.1% above analysts’ consensus estimates.
Via StockStory · August 4, 2025
Medical technology company Inspire Medical Systems (NYSE:INSP) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 10.8% year on year to $217.1 million. On the other hand, the company’s full-year revenue guidance of $905 million at the midpoint came in 4.6% below analysts’ estimates. Its GAAP loss of $0.12 per share was significantly below analysts’ consensus estimates.
Via StockStory · August 4, 2025
Via Benzinga · August 4, 2025
Via Benzinga · August 4, 2025
Palantir announces second-quarter revenue of $1.004 billion, beating analyst estimates of $939.71 million.
Via Benzinga · August 4, 2025
Online insurance comparison site EverQuote (NASDAQ:EVER) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 33.7% year on year to $156.6 million. The company expects next quarter’s revenue to be around $166 million, coming in 0.9% above analysts’ estimates. Its GAAP profit of $0.39 per share was 9.9% above analysts’ consensus estimates.
Via StockStory · August 4, 2025
Cryptocurrency markets are rallying on Monday, led by notable Ethereum outperformance.
Via Benzinga · August 4, 2025
Packaged foods company B&G Foods (NYSE:BGS) fell short of the market’s revenue expectations in Q2 CY2025, with sales falling 4.5% year on year to $424.4 million. The company’s full-year revenue guidance of $1.86 billion at the midpoint came in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.04 per share was $0.02 below analysts’ consensus estimates.
Via StockStory · August 4, 2025
MercadoLibre stock fell Monday after the Latin American e-commerce company reported mixed second-quarter results.
Via Investor's Business Daily · August 4, 2025
Onsemi is set up for a robust rebound that will likely gain traction late in Q3 2025 and carry the market back to record high levels.
Via MarketBeat · August 4, 2025
Lyft partners with Baidu to launch robotaxis in Europe by 2026.
Via Talk Markets · August 4, 2025
Data-mining and analytics company Palantir (NYSE:PLTR) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 48% year on year to $1.00 billion. On top of that, next quarter’s revenue guidance ($1.09 billion at the midpoint) was surprisingly good and 10.5% above what analysts were expecting. Its non-GAAP profit of $0.16 per share was 15.6% above analysts’ consensus estimates.
Via StockStory · August 4, 2025
The company reiterated its sales outlook for the year, despite coming in with lighter-than-expected second-quarter sales.
Via Investor's Business Daily · August 4, 2025
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 12.1% year on year to $2.96 billion. The company expects the full year’s revenue to be around $11.93 billion, close to analysts’ estimates. Its non-GAAP profit of $4.52 per share was 6.3% above analysts’ consensus estimates.
Via StockStory · August 4, 2025
Diner restaurant chain Denny’s (NASDAQ:DENN) fell short of the market’s revenue expectations in Q2 CY2025 as sales only rose 1.5% year on year to $117.7 million. Its non-GAAP profit of $0.09 per share was 16.3% below analysts’ consensus estimates.
Via StockStory · August 4, 2025
The stock market has been making new all-time highs, leading some to wonder if anything can stop this freight train.
Via Talk Markets · August 4, 2025
Semiconductor designer Lattice Semiconductor (NASDAQ:LSCC) met Wall Street’s revenue expectations in Q2 CY2025, but sales were flat year on year at $124 million. The company expects next quarter’s revenue to be around $133 million, close to analysts’ estimates. Its non-GAAP profit of $0.24 per share was in line with analysts’ consensus estimates.
Via StockStory · August 4, 2025
Analysts expect MP Materials to report a loss of 18 cents per share and $46.31 million in revenue for Q2 earnings on Thursday.
Via Benzinga · August 4, 2025
Via Benzinga · August 4, 2025
Palantir Q2 earnings beat estimates. Strong revenue growth in the U.S. government business boosted financial results for Palantir stock.
Via Investor's Business Daily · August 4, 2025
Transmission provider Allison Transmission (NYSE:ALSN) beat Wall Street’s revenue expectations in Q2 CY2025, but sales were flat year on year at $814 million. On the other hand, the company’s full-year revenue guidance of $3.13 billion at the midpoint came in 1.3% below analysts’ estimates. Its GAAP profit of $2.29 per share was 2.9% above analysts’ consensus estimates.
Via StockStory · August 4, 2025
The AI chip maker received high marks from pundits tracking its fortunes.
Via The Motley Fool · August 4, 2025
Rumors of CPI manipulation are spreading after Trump's tariffs, but BLS simulations show the data remains reliable.
Via Benzinga · August 4, 2025
Via Benzinga · August 4, 2025